Samsara Other Non-Current Liabilities increased by 82.3% to $13.26M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 100.3%, from $6.62M to $13.26M. Over 4 years (FY 2022 to FY 2026), Other Non-Current Liabilities shows an upward trend with a 18.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.69M | $3.60M | $6.51M | $7.38M | $9.51M | $9.08M | $9.28M | $9.30M | $9.94M | $9.65M | $9.18M | $8.49M | $6.62M | $7.37M | $7.17M | $7.28M | $13.26M |
| QoQ Change | — | -46.2% | +80.7% | +13.4% | +28.8% | -4.5% | +2.3% | +0.2% | +6.9% | -2.9% | -4.8% | -7.5% | -22.0% | +11.4% | -2.7% | +1.4% | +82.3% |
| YoY Change | — | — | — | — | +42.1% | +152.0% | +42.7% | +26.0% | +4.5% | +6.3% | -1.1% | -8.6% | -33.3% | -23.6% | -21.9% | -14.3% | +100.3% |